Key details
Phase
Early testing / Safety & dosing
Sponsor
Rigshospitalet, Denmark
Enrollment target
~40 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated February 2025